Middle East & Africa Genetic Testing Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The Middle East & Africa genetic testing services market size is expected to reach US$ 236.91 million by 2031 from US$ 87.99 million in 2023. The market is estimated to record a CAGR of 13.2% from 2023 to 2031.

Executive Summary and Middle East & Africa Genetic Testing Services Market Analysis:

The Middle East and Africa genetic testing services market is experiencing gradual growth, driven by increasing awareness of genetic diseases, advancements in healthcare infrastructure, and rising demand for personalized medicine. In the region, countries like the UAE, Saudi Arabia, and South Africa are leading the adoption of genetic testing services, with a focus on prenatal screening, cancer diagnosis, and rare genetic disorder detection. Growing healthcare investments, along with improving access to advanced medical technologies, are enhancing the availability of genetic testing in these regions. Additionally, the rise in chronic diseases and the region's focus on improving health outcomes have further boosted market demand. The integration of next-generation sequencing (NGS) and advancements in genetic counseling are expected to further support market growth. However, the market faces challenges such as high testing costs and limited awareness in certain areas, but the increasing focus on healthcare development presents opportunities for future growth.

Middle East & Africa Genetic Testing Services Market Strategic Insights

Get more information on this report Request Free Sample PDF

Middle East & Africa Genetic Testing Services Market Segmentation Analysis

Key segments that contributed to the derivation of the genetic testing services market analysis are service type, disease, and service provider.

• By service type, the genetic testing services market is segmented into predictive testing, carrier testing, prenatal testing, newborn screening, diagnostic genetic testing, and others. The predictive testing segment held the largest share of the market in 2023.
• By disease, the genetic testing services market is segmented into cancer, cardiovascular diseases, metabolic diseases, and other diseases. The cancer segment held the largest share of the market in 2023.
• By service provider, the genetic testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and other service provider. The hospital-based laboratories segment held the largest share of the market in 2023.

Middle East & Africa Genetic Testing Services Market Outlook

As of 2018, there were ~75,000 genetic tests available in the market, with nearly ten new tests entering the market every day. As per the study "Trends in Availability of Genetic Tests in the United States, 2012–2022," published in 2023, ~129,624 and 197,779 genetic tests in the US and globally, respectively, have been made accessible and submitted to the genetic testing registry as of November 2022. These tests have been extended from single-gene tests to panels that look at multiple genes. Whole-genome sequencing and now whole-exome sequencing have also become more popular. To solve the growing problem of health data exhaust, the field of medicine is increasingly revolving around enhanced clinical tools, such as artificial intelligence (AI) and machine learning, which have been mentioned as a way to improve the acceptance of genomic medicine. Today, many companies have turned to machine learning to process the vast amount of data needed to correctly analyze and understand clinical data in fields such as radiology and cardiology.

Many of the consumer-facing genetic testing technologies that are available in the market are using machine learning or AI to function. In numerous ways, genetic testing of diseases is the perfect field for machine learning because of the vast volumes of data that these programs need to struggle with. For example, working on the human genome includes reading billions of bits of information, and prior to the introduction of machine learning, many of these tasks were pretty tricky. AI offers great potential when it comes to analyzing genetic data and supporting clinical specialists in making diagnoses.

Google has a program called Deep Variant that can now be used to plot the human genome thoroughly and can be used on the full range of a person's genetic information. Moreover, agencies such as the National Institutes of Health are working on ways through which machine learning and AI can add to a better understanding of genetics and genomics. Furthermore, Blueprint Genetics is using AI in clinical interpretation. Machine learning and AI are acting as a catalyst for faster and more diverse improvement in genetic research and engineering. These tools are simple to integrate and extremely scalable, putting genetic laboratories in a unique position to scale their operations and match the fast growth of the genetic testing field. Thus, through the successful integration of these tools, clinicians will be able to diagnose rare genetic diseases more efficiently and effectively, bringing hope to the millions of people affected by them globally.

Middle East & Africa Genetic Testing Services Market Country Insights

Based on country, the Middle East & Africa genetic testing services market comprises Saudi Arabia, South Arica, the UAE, and the Rest of Middle East & Africa. South Africa held the largest share in 2023.

The UAE is always at the forefront of providing the best facilities to its citizens and believes in building a healthy society for its citizens. In 2019, the UAE government launched an initiative to set up a state-of-the-art Genome Center to use the benefits of genetic science. It also focused on the implementation of modern and novel techniques, which consist of DNA sequencing, profiling, and microarray. The initiative intends to control the spread of non-communicable diseases such as cancer and provide the platform to create personalized medicine programs for patients. The Ministry of Health and Prevention (MOHAP) also collaborated with Pure Health Laboratory Network to launch the first phase of the genome center in the country. The aim is to create a genome database for all genetic diseases in the UAE. In November 2023, the Department of Health–Abu Dhabi (DoH), in line with its continuous efforts to upskill the national healthcare workforce, launched the Clinical Genomic Medicine and Genetic Counselling Program for 100 Emirati physicians from diverse healthcare facilities across the country. The six-month program is the region's first program offered by experts from Harvard Medical School Teaching Hospitals. It aims to equip medical professionals with the essential knowledge and skills to handle genetic and genomic issues in the clinical setting. Similarly, in November 2022, Illumina inaugurated its Illumina Solutions Centre in Dubai. The Centre is furnished with genetic testing equipment, such as a fully operational lab with the latest NGS technologies. It offers training in diagnostic tests, such as noninvasive prenatal screening or genomic tests for cancer. Thus, the factors mentioned above are likely to support the genetic testing services market growth in the country during the forecast period

Middle East & Africa Genetic Testing Services Market Report Highlights

Middle East & Africa Genetic Testing Services Market Company Profiles

Some of the key players operating in the market include Eurofins Scientific SE, Exact Sciences Corp, Laboratory Corp of America Holdings, 23andMe Holding Co, Ambry Genetics Corp, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd, NeoGenomics Inc, Centogene NV, Ancestry Genomics Inc, Gene By Gene Ltd, SIVOTEC BioInformatics LLC, Progenesis, Fulgent Genetics, Inc, VERITAS INTERCONTINENTAL, and GeneDx, LLC among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East & Africa Genetic Testing Services Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners’ conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Middle East & Africa Genetic Testing Services Market Country and Regional Insights